Sanofi (FRA:SNW2)

Market Cap	96.10B -26.3%
Revenue (ttm)	46.72B +5.5%
Net Income	7.81B +40.5%
EPS	6.37 +43.6%
Shares Out	n/a
PE Ratio	12.30
Forward PE	9.54
Dividend	1.42 (3.69%)
Ex-Dividend Date	May 9, 2025

Volume	n/a
Average Volume	20
Open	39.60
Previous Close	39.00
Day's Range	39.40 - 39.60
52-Week Range	38.20 - 54.50
Beta	n/a
RSI	47.34
Earnings Date	Jan 29, 2026

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, COVID-19 vaccine Nuvaxovid, booster, meningitis, and travel and endemic vaccines, that in...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 74,846
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: SNW2

Financial Performance

In 2025, Sanofi's revenue was 46.72 billion, an increase of 5.49% compared to the previous year's 44.29 billion. Earnings were 7.81 billion, an increase of 40.52%.